Septerna, Inc. (SEPN)
38.89
-0.24
(-0.61%)
USD |
NASDAQ |
Oct 01, 13:49
Septerna Total Assets (Quarterly) : 566.74M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 566.74M |
| March 31, 2026 | 569.69M |
| December 31, 2025 | 601.98M |
| September 30, 2025 | 606.65M |
| June 30, 2025 | 415.23M |
| March 31, 2025 | 434.02M |
| Date | Value |
|---|---|
| December 31, 2024 | 456.55M |
| September 30, 2024 | 174.28M |
| June 30, 2024 | 176.63M |
| March 31, 2024 | |
| December 31, 2023 | 130.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 4.649M |
| CNBX Pharmaceuticals, Inc. | 0.0128M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 675.10M |
| Fulcrum Therapeutics, Inc. | 323.95M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 180.02M |
| Shareholders Equity (Quarterly) | 386.72M |
| Debt to Equity Ratio | 0.0583 |
| Current Ratio | 4.995 |
| Net Debt Paydown Yield | 0.03% |